Skip to main navigation
Skip to search
Skip to main content
Research Profiles at Washington University School of Medicine Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Germline HSD3B1 Genetics and Prostate Cancer Outcomes
Lewis Thomas
, Nima Sharifi
Siteman Cancer Center
Division of Urologic Surgery
Research output
:
Contribution to journal
›
Review article
›
peer-review
24
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Germline HSD3B1 Genetics and Prostate Cancer Outcomes'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Germ Cells
100%
Prostate Cancer Outcomes
100%
HSD3B1
100%
Dihydrotestosterone
75%
Prostate Cancer
25%
Worse Outcome
25%
Clinical Data
25%
Poor Outcome
25%
Enzymatic Conversion
25%
Tumor Tissue
25%
Hydroxysteroid Dehydrogenase
25%
Low Volume
25%
Castration-resistant Prostate Cancer
25%
Enzalutamide
25%
Castration
25%
Multiple Cohorts
25%
Abiraterone
25%
Androgen Synthesis
25%
DHEA Sulfate
25%
Medicine and Dentistry
Prostate Cancer
100%
Allele
100%
Androstanolone
100%
Germ Cell
100%
Neoplasm
33%
Castration Resistant Prostate Cancer
33%
Prasterone
33%
Abiraterone
33%
Enzalutamide
33%
Androgen Synthesis
33%
3(or 17)beta Hydroxysteroid Dehydrogenase
33%
Prasterone Sulfate
33%
Biochemistry, Genetics and Molecular Biology
Germline
100%
Germ Cell
100%
Genetics
100%
HSD3B1
100%
Allele
75%
Enzyme
25%
Hydroxysteroid Dehydrogenase
25%
Androgen Synthesis
25%
Enzalutamide
25%
Dehydroepiandrosterone
25%
Dehydroepiandrosterone Sulfate
25%